<DOC>
	<DOCNO>NCT01529944</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial obtain PTPN11 mutation status investigate impact PTPN11 mutation status effect somatropin ( Norditropin® ) use data obtain GHNOO-1658 trial .</brief_summary>
	<brief_title>Genetic Testing Noonan Subjects Previously Treated With Norditropin® . An Extension Trial GHNOO-1658</brief_title>
	<detailed_description />
	<mesh_term>Noonan Syndrome</mesh_term>
	<criteria>Participation GHNOO1658 trial Subject complete genetic test PTPN11 mutation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>